|
a |
|
b/Manuscripts/CDS-Bevacizumab-LLMs/README.md |
|
|
1 |
<div align="left"> |
|
|
2 |
|
|
|
3 |
<br> |
|
|
4 |
|
|
|
5 |
Kawchak K. Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968162 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International. |
|
|
6 |
|
|
|
7 |
[](https://doi.org/10.5281/zenodo.14968162) |
|
|
8 |
|
|
|
9 |
|
|
|
10 |
|
|
|
11 |
<div align="left"> |
|
|
12 |
|
|
|
13 |
<br> |
|
|
14 |
|
|
|
15 |
Kawchak K. Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968289 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International. [Full Study](https://doi.org/10.5281/zenodo.14968162) |
|
|
16 |
|
|
|
17 |
[](https://doi.org/10.5281/zenodo.14968289) |
|
|
18 |
|
|
|
19 |
|
|
|
20 |
|
|
|
21 |
|
|
|
22 |
## AI Applications for Drug Industry |
|
|
23 |
LLM and LLM agent pharmaceutical industry applications |
|
|
24 |
|
|
|
25 |
[](https://doi.org/10.5281/zenodo.13273141) |